Company
Headquarters: Tokyo, Japan
Employees: 3,291
CEO: Mr. Kotaro Fukuda
¥187.86 Billion
JPY as of July 1, 2025
US$1.31 Billion
| Company | Market Cap (USD) |
|---|---|
| Abbott | $233.33 B |
| Boston Scientific Corporation | $154.34 B |
| Stryker | $151.06 B |
| Medtronic | $113.25 B |
| Edwards Lifesciences Corporation | $45.05 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Fukuda Denshi Co., Ltd. develops, manufactures, and sells medical electronic equipment worldwide. It provides resting electrocardiograph products; data management software; stress test products; Holter products and software; and patient monitoring systems, including central and bedside monitors, digital transmitters, and central viewer workstations. The company also offers defibrillator monitors; and ultrasound systems, as well as vascular screening systems. Fukuda Denshi Co., Ltd. was founded in 1939 and is based in Tokyo, Japan.
| Last Financial Reports Date | June 30, 2024 |
| Revenue TTM | ¥139.01 B |
| EBITDA | ¥36.97 B |
| Gross Profit TTM | ¥73.82 B |
| Profit Margin | 13.38% |
| Operating Margin | 21.42% |
| Quarterly Revenue Growth | -3.50% |
Fukuda Denshi Co. Ltd has the following listings and related stock indices.
Stock: JPX: 6960 wb_incandescent